found that intraperitoneal injection of TRQ can reduce the infiltration of inflammatory cells, expression and secretion of inflammatory cytokines (TNF-α, IL-6, and IL-1β), and lung fibrosis induced by bleomycin administration (77). This evidence concerns the gene IL1B and pulmonary fibrosis.